Labetalol Infusion Preparation Protocol
For continuous IV infusion, prepare labetalol by mixing 200 mg (40 mL of 5 mg/mL solution) in 160 mL of compatible IV fluid to create a final concentration of 1 mg/mL, then initiate at 0.4-1.0 mg/kg/hour and titrate up to 3 mg/kg/hour based on blood pressure response. 1
Standard Infusion Preparation
- Mix 200 mg of labetalol in 200 mL total volume (typically by adding 40 mL of 5 mg/mL labetalol to 160 mL of D5W or normal saline) to achieve a concentration of 1 mg/mL 1
- Alternative concentrations can be prepared based on institutional protocols, but 1 mg/mL is most commonly used for ease of dosing calculations 2
- Compatible diluents include dextrose 5% in water (D5W), normal saline, or lactated Ringer's solution 2
Dosing Regimen
Initial Dosing
- Start infusion at 0.4-1.0 mg/kg/hour for general hypertensive emergencies 1
- For a 70 kg adult, this translates to approximately 28-70 mg/hour or 0.5-1.2 mL/min of a 1 mg/mL solution 1
Titration Strategy
- Titrate upward every 15-30 minutes by 0.5-1.0 mg/kg/hour increments until blood pressure goal is achieved 1
- Maximum infusion rate is 3 mg/kg/hour 1
- Maximum cumulative dose is 300 mg in 24 hours in most clinical settings 1, 3
Alternative Bolus Plus Infusion Method
- Give loading dose of 1.5 mg/kg IV over 5 minutes, then start maintenance infusion at 0.2 mg/kg/hour 30 minutes later 2
- This approach provides more rapid initial blood pressure control with sustained effect 2
Blood Pressure Targets
- Aim for 10-15% reduction in blood pressure initially, not normalization 1
- For acute stroke candidates requiring thrombolysis: maintain BP <185/110 mmHg 1
- For acute aortic dissection: target systolic BP ≤120 mmHg within 20 minutes 1
Monitoring Requirements
- Continuous or every 5-15 minute blood pressure monitoring during titration phase 1
- Monitor heart rate continuously for bradycardia (labetalol causes 20% reduction in heart rate on average) 2
- Once stable, check BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly 1
- Assess patient tolerance to upright position before ambulation due to risk of orthostatic hypotension 1
Critical Contraindications
Do not use labetalol in patients with: 1
- Second or third-degree AV block
- Significant bradycardia (heart rate <50 bpm)
- Decompensated heart failure
- Reactive airway disease or COPD
- Combination with magnesium sulfate in pregnancy (risk of severe maternal hypotension) 1
Common Pitfalls to Avoid
- Do not attempt to normalize blood pressure rapidly - excessive reduction increases risk of end-organ hypoperfusion 1
- Do not use fixed infusion rates without weight-based dosing - this leads to under- or overdosing 1
- Do not overlook the beta-blocking effects - labetalol reduces cardiac output by approximately 26% and heart rate by 20%, which is therapeutic but requires monitoring 2
- The measured steady-state plasma concentration is often higher than predicted because clearance is lower than expected (13.1 mL/kg/min), so be prepared to use lower maintenance rates than initially calculated 2
Special Population Considerations
Pregnancy/Preeclampsia
- Can use intermittent bolus dosing (10-20 mg IV every 10-30 minutes up to 300 mg total) OR continuous infusion (bolus 12.5-25 mg followed by 5-40 mg/hour) 1
- Never combine with magnesium sulfate due to additive hypotensive effects 1